{"cik":1708331,"entityName":"Virpax Pharmaceuticals, Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-05-14","val":4960153,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}}},"us-gaap":{"AccountsPayableAndAccruedLiabilitiesCurrent":{"label":"Accounts Payable and Accrued Liabilities, Current","description":"Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.","units":{"USD":[{"end":"2020-12-31","val":3115924,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2589520,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AccountsPayableFairValueDisclosure":{"label":"Accounts Payable, Fair Value Disclosure","description":"Fair value portion of liabilities incurred for goods and services received that are used in an entity's business and related party payables.","units":{"USD":[{"end":"2020-03-31","val":1781,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1I"}]}},"AccruedLiabilitiesCurrent":{"label":"Accrued Liabilities, Current","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":270000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":263431,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AccruedProfessionalFeesCurrent":{"label":"Accrued Professional Fees, Current","description":"Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":253462,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":153859,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":6431715,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":22584788,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AdjustmentsToAdditionalPaidInCapitalStockSplit":{"label":"Adjustments to Additional Paid in Capital, Stock Split","description":"Amount of decrease in additional paid in capital (APIC) resulting from a stock split in which per-share par value or stated value is not changed proportionately.","units":{"USD":[{"start":"2018-12-25","end":"2019-01-02","val":113,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2018Q4I"},{"start":"2019-12-25","end":"2020-01-02","val":119,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2019Q4I"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":465406,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":13219342,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":73069,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":13219342,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2019-12-31","val":41536,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2019Q4I"},{"end":"2020-03-31","val":244140,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1I"},{"end":"2020-12-31","val":54796,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":12264285,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2020-12-31","val":54796,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":12264285,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect","description":"Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":202604,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":12209489,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"CommonStockConvertibleConversionPriceIncrease":{"label":"Common Stock, Convertible, Conversion Price, Increase","description":"Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":12.5,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.00001,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0.00001,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":100000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":100000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":3145153,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":4945153,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":3145153,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":4945153,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":31,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":49,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"DebtInstrumentFaceAmount":{"label":"Debt Instrument, Face Amount","description":"Face (par) amount of debt instrument at time of issuance.","units":{"USD":[{"end":"2020-05-04","val":72100,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1I"}]}},"DebtInstrumentIncreaseAccruedInterest":{"label":"Debt Instrument, Increase, Accrued Interest","description":"Increase for accrued, but unpaid interest on the debt instrument for the period.","units":{"USD":[{"start":"2020-04-01","end":"2020-11-30","val":30431,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17"},{"start":"2021-02-01","end":"2021-02-28","val":34544,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"DebtWeightedAverageInterestRate":{"label":"Debt, Weighted Average Interest Rate","description":"Weighted average interest rate of debt outstanding.","units":{"pure":[{"end":"2020-05-04","val":0.01,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1I"}]}},"DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense":{"label":"Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense","description":"Amount of expense recognized from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments), awarded to key employees or individuals. Excludes amount related to plans that cover generally all employees (for example, but not limited to, qualified pension plans).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":130990,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":369884,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"DeferredCompensationLiabilityCurrent":{"label":"Deferred Compensation Liability, Current","description":"Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.","units":{"USD":[{"end":"2020-12-31","val":1028110,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1105060,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"DeferredCosts":{"label":"Deferred Costs, Noncurrent","description":"Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.","units":{"USD":[{"end":"2020-12-31","val":392337,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-03-31","val":-0.22,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-0.6,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":{"label":"Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount","description":"Amount of cost to be recognized for option under share-based payment arrangement.","units":{"USD":[{"end":"2021-03-31","val":142185,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"EquityMethodInvestmentOwnershipPercentage":{"label":"Equity Method Investment, Ownership Percentage","description":"The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.","units":{"pure":[{"end":"2021-03-31","val":0.06,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":448985,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":1273572,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":{"label":"Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest","description":"Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-656495,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-2379271,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities":{"label":"Increase (Decrease) in Accounts Payable and Accrued Liabilities","description":"The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":275026,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-164766,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":{"label":"Increase (Decrease) in Prepaid Expense and Other Assets","description":"Amount of increase (decrease) in prepaid expenses, and assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":5998,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":936784,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"IncrementalCommonSharesAttributableToCallOptionsAndWarrants":{"label":"Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants","description":"Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":90000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"InterestExpense":{"label":"Interest Expense","description":"Amount of the cost of borrowed funds accounted for as interest expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":40630,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":30699,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"InterestExpenseDebt":{"label":"Interest Expense, Debt","description":"Amount of the cost of borrowed funds accounted for as interest expense for debt.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":40630,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":30699,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"InterestPaidNet":{"label":"Interest Paid, Excluding Capitalized Interest, Operating Activities","description":"Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":34707,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":4681504,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":3661620,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":465406,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":13219342,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":3659914,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2640030,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"LiabilitiesNoncurrent":{"label":"Liabilities, Noncurrent","description":"Amount of obligation due after one year or beyond the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":1021590,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1021590,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"LongTermDebt":{"label":"Long-term Debt","description":"Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.","units":{"USD":[{"end":"2021-03-31","val":1072100,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths":{"label":"Long-Term Debt, Maturity, Year One","description":"Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).","units":{"USD":[{"end":"2021-03-31","val":50510,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree":{"label":"Long-Term Debt, Maturity, Year Three","description":"Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).","units":{"USD":[{"end":"2021-03-31","val":1000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo":{"label":"Long-Term Debt, Maturity, Year Two","description":"Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).","units":{"USD":[{"end":"2021-03-31","val":21590,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"LongTermNotesPayable":{"label":"Notes Payable, Noncurrent","description":"Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.","units":{"USD":[{"end":"2020-12-31","val":1021590,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1021590,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":425000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":15289727,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-222396,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-3080238,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-656495,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-2379271,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"NotesAndLoansPayableCurrent":{"label":"Notes and Loans Payable, Current","description":"Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.","units":{"USD":[{"end":"2020-12-31","val":543990,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":50510,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"NotesPayable":{"label":"Notes Payable","description":"Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":1565580,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1072100,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"NotesPayableCurrent":{"label":"Notes Payable, Current","description":"Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.","units":{"USD":[{"end":"2020-12-31","val":543990,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":50510,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"NotesPayableRelatedPartiesCurrentAndNoncurrent":{"label":"Notes Payable, Related Parties","description":"The amount for notes payable (written promise to pay), due to related parties.","units":{"USD":[{"end":"2020-12-31","val":1000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"NotesPayableRelatedPartiesNoncurrent":{"label":"Notes Payable, Related Parties, Noncurrent","description":"The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).","units":{"USD":[{"end":"2020-12-31","val":1000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":615865,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":2348572,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-615865,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-2348572,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"OtherAccountsPayableAndAccruedLiabilities":{"label":"Other Accounts Payable and Accrued Liabilities","description":"Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":19233,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":4656,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"OtherLongTermNotesPayable":{"label":"Other Notes Payable, Noncurrent","description":"Amount of long-term notes classified as other, payable after one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":21590,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":21590,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"OtherNoncashExpense":{"label":"Other Noncash Expense","description":"Amount of expense or loss included in net income that result in no cash flow, classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":32300,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":30699,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"OtherPrepaidExpenseCurrent":{"label":"Other Prepaid Expense, Current","description":"Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":534,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":267,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"PaymentsOfFinancingCosts":{"label":"Payments of Financing Costs","description":"The cash outflow for loan and debt issuance costs.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":2216793,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"PreferredStockParOrStatedValuePerShare":{"label":"Preferred Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.","units":{"USD/shares":[{"end":"2020-12-31","val":0.00001,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0.00001,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"PreferredStockSharesAuthorized":{"label":"Preferred Stock, Shares Authorized","description":"The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":10000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":10000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"PrepaidExpenseAndOtherAssetsCurrent":{"label":"Prepaid Expense and Other Assets, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":18273,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":955057,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"PrepaidInsurance":{"label":"Prepaid Insurance","description":"Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":8257,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":949477,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"ProceedsFromDebtNetOfIssuanceCosts":{"label":"Proceeds from Debt, Net of Issuance Costs","description":"The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":15783207,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"ProceedsFromIssuanceInitialPublicOffering":{"label":"Proceeds from Issuance Initial Public Offering","description":"The cash inflow associated with the amount received from entity's first offering of stock to the public.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":18000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"ProceedsFromIssuanceOfCommonStock":{"label":"Proceeds from Issuance of Common Stock","description":"The cash inflow from the additional capital contribution to the entity.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":425000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"}]}},"ProceedsFromRelatedPartyDebt":{"label":"Proceeds from Related Party Debt","description":"The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":100000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty":{"label":"Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party","description":"Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.","units":{"USD":[{"start":"2018-10-01","end":"2019-01-31","val":1000000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2018Q4"}]}},"RepaymentsOfNotesPayable":{"label":"Repayments of Notes Payable","description":"The cash outflow for a borrowing supported by a written promise to pay an obligation.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":493480,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"RepaymentsOfRelatedPartyDebt":{"label":"Repayments of Related Party Debt","description":"The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":100000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":166880,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":1075000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-10647844,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-13027115,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"SaleLeasebackTransactionGrossProceedsInvestingActivities":{"label":"Sale Leaseback Transaction, Gross Proceeds, Investing Activities","description":"Amount of cash inflow before closing and debt issuance costs received by a seller-lessee in a sale-leaseback recognized in investing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":425000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"}]}},"SaleOfStockPricePerShare":{"label":"Sale of Stock, Price Per Share","description":"Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.","units":{"USD/shares":[{"end":"2020-02-16","val":10,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1I"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":130990,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":369884,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate","description":"The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.","units":{"pure":[{"start":"2020-01-01","end":"2020-03-31","val":0,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate","description":"The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.","units":{"pure":[{"start":"2020-01-01","end":"2020-03-31","val":0.65,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate","description":"The risk-free interest rate assumption that is used in valuing an option on its own shares.","units":{"pure":[{"start":"2020-01-01","end":"2020-03-31","val":0.0169,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate","description":"Rate of weighted-average expected volatility for award under share-based payment arrangement.","units":{"pure":[{"start":"2021-01-01","end":"2021-03-31","val":1,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period","description":"The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.","units":{"shares":[{"start":"2020-01-01","end":"2020-12-31","val":20225,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross","description":"Gross number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2020-01-01","end":"2020-12-31","val":269868,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value","description":"The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-12-31","val":5.66,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2019-12-31","val":236458,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2019Q4I"},{"end":"2020-12-31","val":486101,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":486101,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2019-12-31","val":9.89,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2019Q4I"},{"end":"2020-12-31","val":9.89,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":9.89,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price","description":"Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-12-31","val":9.89,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-12-31","val":9.89,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020"}]}},"SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent","description":"Purchase price of common stock expressed as a percentage of its fair value.","units":{"pure":[{"start":"2018-05-10","end":"2018-05-21","val":1,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2018Q2I"}]}},"SharesIssued":{"label":"Shares, Issued","description":"Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.","units":{"shares":[{"end":"2020-03-31","val":150,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1I"}]}},"SharesIssuedPricePerShare":{"label":"Shares Issued, Price Per Share","description":"Per share or per unit amount of equity securities issued.","units":{"USD/shares":[{"end":"2020-02-16","val":1800000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2019-12-31","val":-2732275,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-2830999,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1I"},{"end":"2020-12-31","val":-4216098,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":9557722,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans":{"label":"Stock Issued During Period, Shares, Employee Stock Purchase Plans","description":"Number of shares issued during the period as a result of an employee stock purchase plan.","units":{"shares":[{"start":"2018-05-10","end":"2018-05-21","val":5056,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2018Q2I"}]}},"StockIssuedDuringPeriodSharesNewIssues":{"label":"Stock Issued During Period, Shares, New Issues","description":"Number of new stock issued during the period.","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":42978,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"}]}},"StockIssuedDuringPeriodSharesStockOptionsExercised":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period","description":"Number of share options (or share units) exercised during the current period.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":323607,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"StockIssuedDuringPeriodValueIssuedForServices":{"label":"Stock Issued During Period, Value, Issued for Services","description":"Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":1781,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"}]}},"StockIssuedDuringPeriodValueNewIssues":{"label":"Stock Issued During Period, Value, New Issues","description":"Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":425000,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"}]}},"StockIssuedDuringPeriodValueOther":{"label":"Stock Issued During Period, Value, Other","description":"Value of shares of stock issued attributable to transactions classified as other.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":15783207,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"StockIssuedDuringPeriodValueShareBasedCompensationGross":{"label":"Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture","description":"Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":130990,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":369884,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}},"UnearnedPremiums":{"label":"Unearned Premiums","description":"Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.","units":{"USD":[{"end":"2020-12-31","val":2874,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q4I"},{"end":"2021-03-31","val":633940,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1I"}]}},"WarrantExercisePriceIncrease":{"label":"Warrant, Exercise Price, Increase","description":"Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-12-31","val":12.5,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-01-01","end":"2020-03-31","val":3044658,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":3945153,"accn":"0001213900-21-026971","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-17","frame":"CY2021Q1"}]}}}}}